Ticker
NRIXCompany Name
NURIX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
9/30/2025 | $ 522.47M | $ 56.49M | 10.81% |
6/30/2025 | $ 591.55M | $ 51.93M | 8.78% |
3/31/2025 | $ 615.04M | $ 26.62M | 4.33% |
12/31/2024 | $ 669.34M | $ 28.3M | 4.23% |
9/30/2024 | $ 513.6M | $ 27.14M | 5.28% |
6/30/2024 | $ 511.03M | $ 28.82M | 5.64% |
3/31/2024 | $ 312.67M | $ 29.16M | 9.32% |
12/31/2023 | $ 355.6M | $ 30.61M | 8.61% |
9/30/2023 | $ 308.19M | $ 8M | 2.6% |
6/30/2023 | $ 350.62M | $ 9.34M | 2.66% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for NURIX THERAPEUTICS INC is calculated as follows: Debt [ $ 0 ] / Assets [ $ 396.34M ]
(=) Debt to Assets [ 0% ]
Minimum
Dec 31, 2020
Maximum
Sep 30, 2025
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.51% |